Table of contents

Clinical and epidemiological research

• Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register (15 April, 2008)

  F H M Prince, M Twilt, R ten Cate, M A J van Rossum, W Armbrust, E P A H Hoppenreijs, M van Santen-Hoeufft, Y Koopman-Keemink, N M Wulffraat, L W A van Suijlekom-Smit
• Long-term outcome following total knee arthroplasty: a controlled longitudinal study (29 July, 2008)

  J Cushnaghan, J Bennett, I Reading, P Croft, P Byng, K Cox, P Dieppe, D Coggon, C Cooper
• Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register (8 May, 2008)

  J Askling, E Baecklund, F Granath, P Geborek, M Fored, C Backlin, L Bertilsson, L Cöster, L T Jacobsson, S Lindblad, J Lysholm, S Rantapää-Dahlqvist, T Saxne, R van Vollenhoven, L Klareskog, N Feltelius
• Laboratory and febrile features after joint surgery in patients with rheumatoid arthritis treated with tocilizumab (2 June, 2008)

  M Hirao, J Hashimoto, H Tsuboi, A Nampei, H Nakahara, N Yoshio, T Mima, H Yoshikawa, N Nishimoto
• Risk factors for major infections in Wegener granulomatosis: analysis of 113 patients (26 May, 2008)

  C Charlier, C Henegar, O Launay, C Pagnoux, A Berezné, B Bienvenu, P Cohen, L Mouthon, L Guillevin
• Familial aggregation of psoriatic arthritis (4 June, 2008)

  V Chandran, C T Schentag, J E Brockbank, F J Pellett, S Shanmugarajah, S M A Toloza, P Rahman, D D Gladman
• The balance between severe cardiovascular and gastrointestinal events among users of selective and non-selective non-steroidal anti-inflammatory drugs (21 May, 2008)

  M W van der Linden, S van der Bij, P Welsing, E J Kuipers, R M C Herings
• One year change of knee cartilage morphology in the first release of participants from the Osteoarthritis Initiative progression subcohort: association with sex, body mass index, symptoms and radiographic osteoarthritis status (2 June, 2008)

  F Eckstein, S Maschek, W Wirth, M Hudelmaier, W Hitzl, B Wyman, M Nevitt, M-P Hellio Le Graverand, the OAI Investigator Group
• Measuring quality of care for rheumatic diseases using an electronic medical record (29 May, 2008)

  J C Agnew-Blais, J S Coblyn, J N Katz, R J Anderson, J Mehta, D H Solomon
• Work disability and health-related quality of life in males and females with psoriatic arthritis (29 May, 2008)

  M Wallenius, J F Skomsvoll, W Koldingsnes, E Rødevand, K Mikkelsen, C Kaufmann, T K Kvien
• Investigating the determinants of international differences in the prevalence of chronic widespread pain: evidence from the European Male Ageing Study (24 July, 2008)

  G J Macfarlane, S R Pye, J D Finn, F C W Wu, A J Silman, G Bartfai, S Boonen, F Casanueva, G Forti, A Giwercman, T S Han, I T Huhtaniemi, K Kula, M E J Lean, T W O’Neill, N Pendleton, M Punab, D Vanderschueren, and the EMAS Study Group
• Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label study (28 July, 2008)

  M Rudwaleit, E Rødevand, P Holck, J Vanhoof, M Kron, S Kary, H Kupper
• Adalimumab for long-term treatment of psoriatic arthritis: 2-year data from the Adalimumab Effectiveness in Psoriatic Arthritis Trial (ADEPT) (6 August, 2008)

  P J Mease, P Ory, J T Sharp, C T Ritchlin, F Van den Bosch, F Wellborne, C Birbara, G T D Thomson, R J Perdok, J Medich, R L Wong, D D Gladman